Mater Research is a recognised leader in medical research. Our bench to bedside philosophy sees us working across Mater Health’s hospitals and health services, The University of Queensland, and the world-class Translational Research Institute (TRI). We are committed to working closely with Mater Health, Mater Education and our growing network of partners and collaborators to turn scientific discovery into the best possible treatment, care, and outcomes for patients and our broader community. 

Our key focus areas are Cancer biology and care , Chronic disease biology and care , Implementing evidence to improve health , Mothers', babies and women's health , Neurosciences and cognitive health , Optimising acute care .

App hopes to reduce stillbirths by 30 per cent
A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.
Mater Research Student Information Evening
Our free student information evening on Thursday 21 February 2019 is a valuable opportunity for undergraduate and postgraduate students enrolled in a Medical, Biomedical, Public Health, Epidemiology, Psychology or Allied Health degree to learn more about current Mater Research programs, upcoming opportunities, as well as meet and network with key Mater Research staff, current students and early career researchers.
Latest News

Dr Seth Cheetham has been awarded three grants to fund research projects addressing the role of genomic plasticity in cancer treatment.

12

Feb

Mater Researcher secures trio of funding for cancer research

Cognitive Neurologist Professor Peter Nestor has been appointed to the position of Clinical Program Leader of the Neurosciences and Cognitive...

11

Feb

Professor Nestor appointed Clinical Program Leader of Neurosciences at Mater

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

04

Feb

New test predicts breast cancer patients at risk of relapse

As of Thursday 24 January 2019 it will be a mandatory requirement for signatures to be collected in electronic format only on the Mater SSA.

23

Jan

Changes to Site-Specific Assessment Submissions at Mater

Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.

09

Jan

New Mater Group CEO takes the reins

Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.

12

Dec

Mater Research awarded $1.84 million in NHMRC funding

Mater researchers have shown that new applications of existing drugs has the potential to improve quality of life for people with Myasthenia...

06

Dec

New applications of drugs could reduce side effects for Myasthenia gravis patients

Dr Sam Bora has been promoted to Associate Professor at Mater Research and UQ's Faculty of Medicine.

06

Dec

Mater Researcher receives Associate Professorship

The Mater Research Awards and Young Investigator Symposium was held on Friday 29 November

04

Dec

Mater Research Awards and Young Investigator Symposium

Mater Group is proud to mark a milestone in its history, the launch of a new brand.

21

Nov

We’re Mater, and we’re better together